Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 20 member 1 (SLC20A1), also known as Glvr-1 or PiT-1, is a sodium-dependent inorganic phosphate transporter that plays a critical role in maintaining cellular phosphate homeostasis [1, 6]. It was originally identified as the cellular receptor for the gibbon ape leukemia virus (GALV) and feline leukemia virus subgroup B (FeLV-B) [1, 3]. Beyond its role in viral entry, SLC20A1 is essential for various physiological processes, including bone mineralization and cell proliferation, and its knockout is embryonic lethal in mice [7, 40]. In disease contexts, overexpression of SLC20A1 is associated with vascular calcification and is a poor prognostic marker in several cancers, including breast and prostate cancer, where it promotes aggressive tumor growth and resistance to therapy [24, 43]. While no drugs are currently approved specifically to target SLC20A1, it is an active area of research for therapeutic intervention in calcification disorders and oncology, with experimental inhibitors like EOS789 showing promise in preclinical studies [40].
Inhibition of sodium-dependent phosphate transport
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 20 member 1 (SLC20A1) (SLC20A1).